Estrella Immunopharma (ESLA) CFO adds 100K shares via option exercise
Rhea-AI Filing Summary
Estrella Immunopharma, Inc. (ESLA) reported that its Chief Financial Officer, Jiandong Xu, exercised 100,000 Incentive Share Options on 2026-08-18 at an exercise price of $0.815 per share, receiving an equal number of common shares. Following the exercise, Xu directly holds 365,488 shares of common stock and 390,796 incentive share options. The options exercised were granted on 2024-10-30 under the 2023 Omnibus Incentive Plan and were vested as to the shares exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 100,000 shares
Net Buy
2 txns
Insider
Xu Jiandong
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Share Option F3, F4 | 100,000 | -- | -- |
| Exercise | Common Stock, par value $0.0001 per share F1, F2 | 100,000 | $0.815 | $82K |
Holdings After Transaction:
Incentive Share Option — 390,796 shares (Direct);
Common Stock, par value $0.0001 per share — 365,488 shares (Direct)
Footnotes (4)
- F1. Represents the exercise price per share paid by the Reporting Person upon the exercise of the stock options reported in Table II.
- F2. Reflects the 265,488 shares of Common Stock directly beneficially owned as reported on the Reporting Person's most recent Form 4, plus the 100,000 shares acquired upon the reported exercise.
- F3. Represents incentive share options granted to the Reporting Person on October 30, 2024 under the Issuer's 2023 Omnibus Incentive Plan, of which twenty-five percent (25%) was immediately exercisable on the date of grant, with the remainder vesting in equal monthly installments of 1/48th of the total award on each monthly anniversary of October 30, 2024. The options were vested as to the shares exercised.
- F4. Not applicable - the reported transaction is the exercise of the stock option for the exercise price set forth in Column 2; no separate consideration was paid or received for the derivative security.
Key Figures
Options exercised: 100,000 shares
Exercise price per share: $0.815 per share
Common stock holdings after transaction: 365,488 shares
+5 more
8 metrics
Options exercised
100,000 shares
Incentive Share Options exercised on 2026-08-18
Exercise price per share
$0.815 per share
Exercise price for Incentive Share Options
Common stock holdings after transaction
365,488 shares
Directly owned by Jiandong Xu after exercise
Option holdings after transaction
390,796 options
Incentive Share Options remaining after exercise
Option grant date
2024-10-30
Grant date of Incentive Share Options under 2023 Omnibus Incentive Plan
Option expiration date
2034-10-29
Expiration of Incentive Share Options exercised
Immediate vesting portion
25%
Portion of award immediately exercisable on grant date
Monthly vesting installments
1/48th per month
Remaining options vest monthly after 2024-10-30
Key Terms
Incentive Share Option, 2023 Omnibus Incentive Plan, exercise price, vested
4 terms
2023 Omnibus Incentive Plan financial
"granted to the Reporting Person on October 30, 2024 under the Issuer's 2023 Omnibus Incentive Plan"
exercise price financial
"Represents the exercise price per share paid by the Reporting Person upon the exercise"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested financial
"The options were vested as to the shares exercised"
FAQ
What insider transaction did ESLA CFO Jiandong Xu report on this Form 4?
Jiandong Xu reported exercising 100,000 Incentive Share Options on 2026-08-18, converting them into 100,000 shares of common stock of Estrella Immunopharma, Inc.
At what price were Jiandong Xu’s ESLA stock options exercised?
The options were exercised at an exercise price of $0.815 per share, which represents the price paid by Jiandong Xu upon the exercise of the stock options.
Did Jiandong Xu pay any additional consideration for the ESLA derivative security itself?
No. The filing states that no separate consideration was paid or received for the derivative security; only the $0.815 per share exercise price was paid upon exercising the stock options.
AI-generated analysis. How Rhea-AI works. Not financial advice.
